New research shows horizontal gene transfer is predictable in bacteria by machine learning, a development that could lead to better weapons in the war against E. coli and other bacterial assailants that collaborate to conquer pharmacologic first responders.  

The new digital journal expects to start seeking submissions later this year. 

Could AI help produce a unifying concept of human disease—one that might help prevent, mitigate or cure everything from birth defects and rare cancers to immune disorders and neurological defects?

Famed billionaire Mark Cuban is entering the world of pharmacy benefit management. 

The AI development team was guided by a sports-medicine specialist dubbed “the go-to orthopedic surgeon for many of the greatest athletes on the planet.”

Physician bias can create disparities in patient care, and the team behind a new program at the University of Arizona hopes to address that issue. 

More than one-quarter of the U.S. adult population has Gastroesophageal Reflux Disease, or GERD, and the condition saddles as many as 20% of its sufferers with Barrett’s esophagus. The latter is a serious risk factor for esophageal cancer.

What do these findings say about current billing policies?